SNIFF study to examine safety and efficacy of nasal insulin for treating Alzheimer ’s

Neurologists at the Rush Alzheimer's Disease Center are conducting an 18-month clinical trial testing a type of insulin delivered in a nasal spray used to treat diabetes in some patients - in the Study of Nasal Insulin to Fight Forgetfulness (SNIFF).News Medical
Source: Society for Endocrinology - Category: Endocrinology Source Type: news